These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 12029439

  • 1. Expression of c-kit protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine status.
    Tsuura Y, Suzuki T, Honma K, Sano M.
    J Cancer Res Clin Oncol; 2002 May; 128(5):239-46. PubMed ID: 12029439
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A, Arkadopoulos N, Gennatas C, Michalaki V, Frangou-Plegmenou M, Chatzipantelis P.
    Tumori; 2010 May; 96(6):978-84. PubMed ID: 21388062
    [Abstract] [Full Text] [Related]

  • 5. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N, Thor A, Page DL, Hand PH, Halter SA, Schlom J.
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [Abstract] [Full Text] [Related]

  • 6. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
    Sawyer EJ, Poulsom R, Hunt FT, Jeffery R, Elia G, Ellis IO, Ellis P, Tomlinson IP, Hanby AM.
    J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of c-erbB-2 oncogene and p53 tumor suppressor gene in benign and malignant breast tissue: correlation with proliferative activity and prognostic index.
    Alexiev BA, Bassarova AV, Popovska SL, Popov AA, Christov CZ.
    Gen Diagn Pathol; 1997 Jun; 142(5-6):271-9. PubMed ID: 9228249
    [Abstract] [Full Text] [Related]

  • 9. Nuclear morphometry of benign and malignant breast lesions.
    Skjørten F, Kaaresen R, Jacobsen U, Skaane P, Amlie E.
    Eur J Surg Oncol; 1991 Aug; 17(4):350-3. PubMed ID: 1874292
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P, Akram M, Benezra R, Brogi E.
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [Abstract] [Full Text] [Related]

  • 12. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues.
    Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A.
    Cancer Res; 1992 Nov 15; 52(22):6139-43. PubMed ID: 1384954
    [Abstract] [Full Text] [Related]

  • 13. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
    Gould VE, Mosquera JM, Leykauf K, Gattuso P, Dürst M, Alonso A.
    Hum Pathol; 2005 May 15; 36(5):536-45. PubMed ID: 15948121
    [Abstract] [Full Text] [Related]

  • 14. Detection by immunohistochemistry of c-erbB2 oncoprotein in breast carcinomas and benign mammary lesions.
    Edorh A, Leroux A, N'sossani B, Parache RM, Rihn B.
    Cell Mol Biol (Noisy-le-grand); 1999 Sep 15; 45(6):831-40. PubMed ID: 10541479
    [Abstract] [Full Text] [Related]

  • 15. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
    Sasano H, Frost AR, Saitoh R, Matsunaga G, Nagura H, Krozowski ZS, Silverberg SG.
    Anticancer Res; 1997 Sep 15; 17(3C):2001-7. PubMed ID: 9216657
    [Abstract] [Full Text] [Related]

  • 16. Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas.
    Chappell SA, Johnson SM, Shaw JA, Walker RA.
    J Pathol; 2000 Oct 15; 192(2):159-65. PubMed ID: 11004691
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R, Carolin K, Wallis T, Visscher DW.
    Hum Pathol; 2003 Mar 15; 34(3):234-9. PubMed ID: 12673557
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
    Cîmpean AM, Raica M, Nariţa D.
    Rom J Morphol Embryol; 2005 Mar 15; 46(2):123-9. PubMed ID: 16286998
    [Abstract] [Full Text] [Related]

  • 19. Hormones and progeny of breast tumor cells.
    Schneider HP, Böcker W.
    Climacteric; 2006 Apr 15; 9(2):88-107. PubMed ID: 16698656
    [Abstract] [Full Text] [Related]

  • 20. CD117 and CD34 staining patterns in childhood benign mammary lesions.
    Kaçar A, Paker I, Akbiyik F, Arikök AT, Mambet E.
    Turk Patoloji Derg; 2012 Apr 15; 28(1):31-7. PubMed ID: 22207429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.